<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several studies have suggested that the partially fermentable fibre Plantago ovata husk (PO) may have a protective effect on <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the potentially pro-apoptotic effect of PO and the implicated mechanisms in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells with different molecular phenotypes (Caco-2, HCT116, LoVo, HT-29, SW480) after PO anaerobic fermentation with colonic bacteria as it occurs in the human colon </plain></SENT>
<SENT sid="2" pm="."><plain>The fermentation products of PO induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> and metastatic cell lines, independent of p53, <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath>, β-catenin or cyclo-oxygenase-2 status </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was caspase-dependent and both intrinsic and extrinsic pathways were implicated </plain></SENT>
<SENT sid="4" pm="."><plain>The intrinsic pathway was activated through a shift in the balance towards a pro-apoptotic environment with an up-regulation of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> protein 2 homologous <z:chebi fb="68" ids="48706">antagonist</z:chebi> killer (BAK) and a down-regulation of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-extra large (Bcl-xL) seen in HCT116 and LoVo cells </plain></SENT>
<SENT sid="5" pm="."><plain>This resulted in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane depolarisation, increased expression of caspase activators second mitochondria-derived activator of caspases (Smac)/Diablo, <z:hpo ids='HP_0011420'>death</z:hpo> effector <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing factor, apoptosome member apoptotic protease activating factor 1 and down-regulation of inhibitors of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> Survivin and <z:hpo ids='HP_0001417'>X-linked</z:hpo> inhibitor of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in most cells </plain></SENT>
<SENT sid="6" pm="."><plain>The extrinsic pathway was activated presumably through the up-regulation of <z:hpo ids='HP_0011420'>death</z:hpo> receptor (DR5) </plain></SENT>
<SENT sid="7" pm="."><plain>Some important differences were seen between <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> and metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, metastatic PO-treated LoVo cells had a remarkable up-regulation of TNF-α ligand along with <z:hpo ids='HP_0011420'>death</z:hpo>-inducing signalling complex components receptor interacting protein and TNF-α receptor 1-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein </plain></SENT>
<SENT sid="9" pm="."><plain>The extrinsic pathway modulator FCICE-inhibitory protein (FLIP), an inhibitor of both spontaneous <z:hpo ids='HP_0011420'>death</z:hpo> ligand-independent and <z:hpo ids='HP_0011420'>death</z:hpo> receptor-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, was significantly down-regulated after PO treatment in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> cells, but not in metastatic LoVo </plain></SENT>
<SENT sid="10" pm="."><plain>These findings suggest that PO could potentially be a useful chemotherapy adjuvant </plain></SENT>
</text></document>